PulmPEEPs

Today, we continue our review of the Global Initiative for Asthma (GINA) guidelines on asthma. We’ve covered asthma diagnosis and phenotyping, and the initial approach to therapy. On today’s episode we’re talking about biologic therapies for asthma and will cover … Continue reading →

Discover innovative treatment strategies for infected pleural effusions as the discussion dives into the MIST 2 trial. Learn how the combination of tPA and DNase is reshaping standard care, emphasizing their effectiveness in reducing fluid size and minimizing surgical interventions. The podcast highlights the critical importance of patient selection criteria and protocol adherence in clinical trials. With insights on the dynamics of interventions and patient management, this exploration is a must-listen for anyone interested in advancements in pulmonology.

The hosts delve into the updated GINA Guidelines for asthma management, emphasizing a holistic treatment approach. They highlight effective management strategies, including both pharmacologic and non-pharmacologic techniques. A significant focus is placed on inhaled corticosteroids over short-acting options. The discussion of MART therapy showcases innovative combined inhalers for better patient outcomes. Additionally, they tackle medication dosages and insurance challenges that affect asthma care, stressing the importance of personalized treatment and ongoing patient education.

Dr. Jon Rosenberg, an assistant professor at Westchester Medical Center and neurocritical care expert, joins to tackle the surprising flexibility of prone positioning for patients with elevated intracranial pressure (ICP). He debunks the myth that elevated ICP is an absolute contraindication to proning. The discussion emphasizes careful patient selection and shares successful case examples, especially during COVID-19. Practical tips for ensuring cerebral perfusion while managing potential complications are also highlighted, making this a must-listen for critical care professionals.

Dr. Theodore "Jack" Iwashyna, a prominent critical care physician from Johns Hopkins, joins to discuss the recent drastic cuts to NIH indirect cost payments. He highlights how these changes threaten medical research, education, and the development of young professionals. The conversation delves into the potential impact on healthcare advancements, including critical therapies like CAR T-cell treatments. Iwashyna advocates for community action to safeguard scientific integrity and ensure future medical progress.

Explore key insights from the GINA guidelines on asthma diagnosis and management. The hosts break down complex information, using clinical cases to emphasize the importance of identifying symptoms and environmental triggers. Learn about essential diagnostic tools and how continuous assessment can tailor treatments effectively. They also introduce the '247' mnemonic to differentiate asthma symptoms, enhancing clinical decision-making. Plus, discover practical measures for patient empowerment in monitoring their condition.

Today is our second episode in our collaborative series with BMJ Thorax. Our mission at Pulm PEEPs is to disseminate and promote pulmonary and critical care education, and we highly value the importance of peer reviewed journals in this endeavor. … Continue reading →

Kalaila Pais, an internal medicine resident passionate about pulmonary care and medical education, and Hima Veeramachaneni, a skilled gastroenterologist and critical care fellow, dive deep into the complexities of Tylenol toxicity and acute liver failure. They analyze a riveting case of a patient with severe liver dysfunction, discuss critical diagnostic factors, and highlight management strategies including the use of N-acetylcysteine. The conversation also touches on the emotional challenges faced by healthcare providers when navigating patient recovery and transplant candidacy.

We are excited to be back with a Rapid Fire Journal Club. Today’s episode is hosted by PulmPEEPs Associate Editor, Luke Hedrick, and will delve into the ANDROMEDA-SHOCK trial published in JAMA in 2019. Meet our Guests Jose Meade Aguilar … Continue reading →

In this engaging discussion, Robert Wharton, a pulmonary fellow at Johns Hopkins, and Nicole Ng, an Assistant Professor at Mount Sinai specializing in interstitial lung disease, delve into the complexities of treating Idiopathic Pulmonary Fibrosis (IPF). They analyze the landmark INPULSIS trials and the efficacy of Nintedanib, highlighting its impact on lung function. The duo discusses challenges like participant selection in clinical trials, adverse effects of the drug, and the importance of personalized treatment strategies to improve patient outcomes.